Nuvectis Pharma Inc. logo

Nuvectis Pharma Inc.

NVCT | NASDAQ
Chart Builder DCF Calculator
$21.98
-$0.02 (-0.09%)
At close: Sep 21, 2026, 4:00 PM ET
$21.98
$0 (0.00%)
After-hours: Sep 21, 2026, 4:10 PM ET

Market Data

Market Cap
$583.27M
Enterprise Value
$561.11M
Beta
-0.26
Average Volume
265.24K
Shares Outstanding (Diluted)
23.48M
Shares Change YoY
9.87%
Institutional Ownership
19.30%
Exchange
NASDAQ
ISIN
US67080T1088

Price Performance

Price Change 1M
-9.6%
Price Change 3M
25.2%
Price Change 6M
176.1%
Price Change YTD
158.3%
Price Change 1Y
241.8%
Price Change 3Y
57.7%
Price Change 5Y
576.3%
1M CAGR (ann.)
16.0%
1Y CAGR (ann.)
243.4%
5Y CAGR (ann.)
N/A
All-Time CAGR
51.1%

Valuation

PE Ratio
-16.78
Forward PE
N/A
PEG Ratio
1.12
Forward PEG
-1.62
PS Ratio
N/A
Forward PS
22.40
PB Ratio
64.22
P/FCF Ratio
-22.42
P/Adj. FCF Ratio
-16.97
P/OCF Ratio
-26.48
EV/Sales
N/A
EV/EBIT
-19.40
EV/EBITDA
-19.40
EV/FCF
-21.56
Earnings Yield
-6.0%
FCF Yield
-4.5%
Adj. FCF Yield
-5.9%

Financial Health

Net Cash
$22.16M
Total Debt
$0
Cash & Short-Term Investments
$22.16M
Total Assets
$22.38M
Current Ratio
1.68
Quick Ratio
1.68
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
15.49
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-32.1%

Returns

Return on Assets
-124.5%
Return on Equity
-169.5%
Return on Invested Capital
-317.9%
Return on Capital Employed
-317.9%
Return on Tangible Assets
-124.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-0.4%
EPS CAGR 5Y
1.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-32.8%
FCF CAGR 5Y
-15.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
27.2%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.22
EPS Growth Est (next Q)
-50.0%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$37.33
Price Target Upside
69.8%

Cash Flow

Operating Cash Flow
$-26.02M
Free Cash Flow
$-26.02M
Adj. Free Cash Flow
$-34.36M
FCF Per Share
-$0.83
OCF Per Share
-$0.83
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$0
Operating Income
$-28.87M
EBITDA
$-28.92M
Net Income
$-27.85M
EPS (Diluted)
-$1.31
Revenue / Employee
N/A
Profit / Employee
$-1.74M
Employees
16

© 2026 bestshares.com. All rights reserved.